{"issuance_frequency":"","notes_translated":{"fr":"Ce document aidera les fabricants à préparer une présentation pour obtenir un Avis de conformité pour une drogue contre la COVID-19 en vertu du Règlement. Il décrit également le processus à suivre pour satisfaire aux exigences réglementaires après la mise en marché.","en":"This document will help manufacturers prepare a submission for a notice of compliance for a COVID-19 drug under the Regulations. It also outlines the process for meeting the post-market regulatory requirements."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"c225f4c0-6e98-4329-b89e-bf62b37ea51d","metadata_created":"2021-07-29T12:12:20.919613","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-29T12:12:20.919619","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-29","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["COVID-19","pandémie","médicament COVID-19","modification","Règlement sur les aliments et drogues","médicaments","fabricants","présentation","avis de conformité","exigences réglementaires post-commercialisation"],"en":["COVID-19","pandemic","COVID-19 drug","amendement","Food and Drug Regulations","drugs","manufacturers","submission","notice of compliance","post-market regulatory requirements"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Lignes directrices sur les modifications apportées au Règlement sur les aliments et drogues pour les médicaments contre la COVID-19 : Aperçu","en":"Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Overview"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"c225f4c0-6e98-4329-b89e-bf62b37ea51d","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"daa16459-9ee5-4d7b-82dd-4864a46e3439","related_relationship":"","name_translated":{"fr":"Lignes directrices sur les modifications apportées au Règlement sur les aliments et drogues pour les médicaments contre la COVID-19 : Aperçu","en":"Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Overview"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Overview","language":["en"],"created":"2021-07-29T12:12:20.989057","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/food-drug-regulations-amendments-covid-19.html","last_modified":null,"position":0,"revision_id":"daab651e-c20c-44e7-843a-697705653aa7","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"c225f4c0-6e98-4329-b89e-bf62b37ea51d","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"28b9339b-75f7-409d-b223-010f07d54bb1","related_relationship":"","name_translated":{"fr":"Lignes directrices sur les modifications apportées au Règlement sur les aliments et drogues pour les médicaments contre la COVID-19 : Aperçu","en":"Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Overview"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Overview","language":["fr"],"created":"2021-07-29T12:12:20.989062","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/reglement-aliments-drogues-modifications-covid-19.html","last_modified":null,"position":1,"revision_id":"daab651e-c20c-44e7-843a-697705653aa7","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2021-06-29 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"c225f4c0-6e98-4329-b89e-bf62b37ea51d","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"This document will help manufacturers prepare a submission for a notice of compliance for a COVID-19 drug under the Regulations. It also outlines the process for meeting the post-market regulatory requirements.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Overview","revision_id":"daab651e-c20c-44e7-843a-697705653aa7"}